Influence of patient-reported outcomes on market access decisions in decentralized markets (Brazil, Italy, Spain, and the United States)
To determine how impactful patient-reported outcome (PRO) data from clinical trial programs are on market access decision making in oncology and other disease areas in decentralized markets.
Citation
Hogue, S., Brogan, A., DeMuro, C., Barrett, A., D'Alessio, D., & Bal, V. (2015). Influence of patient-reported outcomes on market access decisions in decentralized markets (Brazil, Italy, Spain, and the United States). Value in Health, 18(3), A212-A212. DOI: 10.1016/j.jval.2015.03.1229
